Lv11
30 积分 2025-04-21 加入
Carfilzomib, lenalidomide, and dexamethasone compared with lenalidomide treatment after autologous haematopoietic stem-cell transplantation in patients with multiple myeloma (ATLAS): primary analysis of a randomised, open-label, phase 3 trial
10小时前
待确认
Prevalence, outcomes, and complications of vitamin D deficiency among patients with multiple myeloma: Nationwide burden of disease
1个月前
已完结
Lisaftoclax: First Approval
4个月前
已完结
Bortezomib, thalidomide, and dexamethasone with or without daratumumab and followed by daratumumab maintenance or observation in transplant-eligible newly diagnosed multiple myeloma: long-term follow-up of the CASSIOPEIA randomised controlled phase 3 trial
6个月前
已完结
Carfilzomib maintenance in newly diagnosed non-transplant eligible multiple myeloma
7个月前
已完结
Epidemiology and Risks of Infections in Patients With Multiple Myeloma Managed With New Generation Therapies
8个月前
已完结
Epidemiology and Risks of Infections in Patients With Multiple Myeloma Managed With New Generation Therapies
8个月前
已完结
Maintenance and continuous therapy for multiple myeloma
8个月前
已完结
International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma
8个月前
已完结
Vaccination in Multiple Myeloma: Review of Current Literature
8个月前
已完结
皖公网安备34019202002308
